Register Login

NLS PHARMACEUTICS LTD. (NCEL)

SymbolNCEL
NameNLS PHARMACEUTICS LTD.
SectorHEALTH CARE
RegionEurope
IndustryBiotechnology: Pharmaceutical Preparations
AddressTHE CIRCLE 6, ZURICH, 8058, Switzerland
Telephone+41 445122150
Fax—
Email—
Websitehttps://www.nlspharma.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001783036
Description

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The companys tangible assets are held in the United States.

Additional info from NASDAQ:
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The companys tangible assets are held in the United States.

2026-07-01 13:30

NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes

Read more
2026-06-18 07:04

New Form EFFECT - NewcelX Ltd. <b>Filed:</b> 2026-06-17 <b>AccNo:</b> 9999999995-26-002036 <b>Size:</b> 1 KB

Read more
2026-06-10 17:16

New Form F-3/A - NewcelX Ltd. <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001213900-26-067333 <b>Size:</b> 724 KB

Read more
2026-05-27 11:55

NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes

Read more
2026-05-18 07:04

New Form EFFECT - NewcelX Ltd. <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 9999999995-26-001675 <b>Size:</b> 1 KB

Read more
2026-05-11 18:07

New Form F-3 - NewcelX Ltd. <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0001213900-26-054555 <b>Size:</b> 751 KB

Read more
2026-05-07 07:06

New Form EFFECT - NewcelX Ltd. <b>Filed:</b> 2026-05-06 <b>AccNo:</b> 9999999995-26-001512 <b>Size:</b> 1 KB

Read more
2026-05-04 17:26

New Form SCHEDULE 13D - NewcelX Ltd. <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001213900-26-051611 <b>Size:</b> 23 KB

Read more
2026-04-30 12:18

NLS PHARMACEUTICS LTD. (NCEL) Files Form 6-K

Read more
2026-04-30 12:15

NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026

Read more